App Logo
menu

Menu

close
expand_more

AML Resources

expand_less
Get connected with cutting edge treatments from specialists
Get Started
pinned-large-article

The Power of Personalized Medicine to Treat Your Acute Myeloid Leukemia with Dr. Stein, Oct 28th @ 2 PM Central

AML News — October 21, 2021

Join us virtually via Zoom on October 28th at 2 PM Central to learn from Dr. Stein of Memorial Sloan Kettering Cancer Center about the importance of a personalized approach for treating your acute myeloid leukemia. Learn about what personalized medicine is, how it can improve your treatment outcomes and the importance of being cared for by an AML specialist. Come with your questions and comments!

Article Image Upcoming Radio Show: The Latest in AML Treatment Advances: Where We Are and Where We're Going with James Blachly, MD, Ohio State University, Oct 25 @ 2 PM CST

Upcoming Events

Oct 25, 2021 / 02:00PM - 03:00PM CDT

The Latest in AML Treatment Advances: Where We Are and Where We're Going with James Blachly, MD, Ohio State University

HealthTree Radio for AML
View details chevron_right

Oct 28, 2021 / 02:00PM - 03:00PM CDT

Virtual Event: The Power of Personalized Medicine to Treat Your Acute Myeloid Leukemia

Adult AML Chapter
View details chevron_right
View all events
list-recent-article

Clinical Trial Update: Ficlatuzumab and Cytarabine Treatment in Relapsed/Refractory AML

The combination of ficlatuzumab and cytarabine could provide an alternative therapeutic option for patients with relapsed or refractory AML that has already shown positive results in an early clinical trial.

list-recent-article

Men and Caregiving Part One: Life as a Male Caregiver

Men are caregivers too! Actually, about 40% of caregivers are men. It's time we include men in the conversation and provide them with the support and resources they need in order to care for their loved ones with AML. Join our AML caregivers Facebook group and AML caregivers chapter to give and receive support. Links in article!
list-recent-article

Moving Toward A Personalized Medicine Approach for Treating AML

The AML research community is making gains on how to best treat AML based on the unique genetic mutations each patient has. FLT3, IDH1, IDH2 and NPM1 are all types of AML mutations that are currently receiving quite a bit of research attention. Learn more about these specific mutations and what it may mean for your treatment regimen.
list-recent-article

Targeted Therapy Using Genome Mapping for Childhood AML and Other Pediatric Cancers

Researchers at St. Jude’s Research Hospital have found that mapping the genome of pediatric cancer patients can help give precision care to those with a cancer diagnosis like AML. Because AML looks and behaves differently from child to child, tumor sequencing can give guidance in making overall treatment decisions that are unique to each patient.
list-recent-article

We’re Going to Take Your Blood Counts to Zero by Kenny Hall, AML and Stem Cell Transplant Survivor

Kenny Hall recounts the experience of his life saving allogeneic stem cell transplant in 2012 at MD Anderson in Houston, Texas. You can read additional posts about his AML experience on his blog at www.cancersportsfaith.wordpress.com

AML News

category-article The Power of Personalized Medicine to Treat Your Acute Myeloid Leukemia with Dr. Stein, Oct 28th @ 2 PM Central Moving Toward A Personalized Medicine Approach for Treating AML FDA Approval Update: Jakafi Approved for Chronic Graft vs Host Disease

Life with AML

category-article From Donor to Recipient, Blood Transfusions Became the Gift of Life for Sam Thomas Men and Caregiving Part One: Life as a Male Caregiver We’re Going to Take Your Blood Counts to Zero by Kenny Hall, AML and Stem Cell Transplant Survivor

Childhood AML

category-article Targeted Therapy Using Genome Mapping for Childhood AML and Other Pediatric Cancers Vyxeos Now FDA Approved for Children With Secondary AML New Study Finds Higher Likelihood of AML in Children With Down Syndrome

AML Clinical Trials

category-article Clinical Trial Update: Ficlatuzumab and Cytarabine Treatment in Relapsed/Refractory AML VOR33 Receives Fast Track Designation to Treat AML What’s New in AML Clinical Trials?

HealthTree University for AML

category-article HealthTree University: Acute Myeloid Leukemia Basics Part 1 (1 of 3)

HealthTree Radio for AML

category-article Upcoming Radio Show: The Latest in AML Treatment Advances: Where We Are and Where We're Going with James Blachly, MD, Ohio State University, Oct 25 @ 2 PM CST Full Radio Show: Harnessing the Immune System in Relapsed/Refractory AML with Dr. John Reagan, Rhode Island Hospital Full Radio Show: The Advancement of Treatment Options for Older Adults with AML with Gabriel Mannis, MD, Stanford Cancer Institute

HealthTree for AML Newsroom

category-article The HealthTree® Foundation Unveils the First and Only Clinical Trial Finder Tool Designed Specifically for Acute Myeloid Leukemia (AML) Patients HealthTree Foundation wants to ease, demystify the clinical trial process for AML patients HealthTree® Foundation Announces the Launch of "HealthTree for Acute Myeloid Leukemia" (AML)

Get the latest thought leadership on AML delivered straight to your inbox.

Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.

Thanks to our HealthTree Community for AML Sponsors:

Follow Us

facebook instagram twitter youtube

 

Terms of Use and Privacy Policy     Newsroom     About    Donations    Find an AML Specialist     Newsletter     Learn     Connect

 

Copyright © 2021 HealthTree Foundation. All Rights Reserved.

The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811